Alex Ralph

Babylon Healthcare, promoted by Matt Hancock, the former health secretary, and once valued at $4.2 billion, collapsed less than two years after floating in New York

Three companies are looking to delist from the junior market and their plans are being put to investors in a series of shareholder votes next week

Cybersecurity role at the vet group had been advertised and the company says the successful candidate will start shortly

Company vows to fight court findings as shares rise 2 per cent

Pharmaceutical giant has agreed to acquire Amolyt Pharma, a clinical-stage biotechnology company focused on endocrine diseases, for about $1 billion

Anglo-Swedish company’s £650 million move was the most eye-catching announcement by Jeremy Hunt in a statement described as ‘unremarkable’

The chancellor announced a levy on e-cigarettes as part of an overall crackdown on smoking

London-listed group argues that most of the large specialist biotechnology investors are based in the United States

British biotechnology company agrees deal with Jazz Pharmaceuticals for the development of its oncology programme

Deloitte is planning to cut about 100 jobs because of the slowdown in corporate dealmaking.The Big Four professional services firm is considering restructuring parts of its advisory corporate finance